ALX Oncology Holdings Inc (ALXO): Shares Outstanding

Annual figures by period end, from SEC filings.

54.39M
As of 2025-12-31
138.22M
As of 2026-06-30
+10.0%
3-year compound annual growth
+6.4%
5-year compound annual growth
2019-12-31: 3.17M2020-12-31: 39.84M2021-12-31: 40.59M2022-12-31: 40.86M2023-12-31: 49.95M2024-12-31: 53.05M2025-12-31: 54.39M54.39M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3154.39M+2.5%2026-03-09, Balance as of period end
2024-12-3153.05M+6.2%2026-03-09, Balance as of period end
2023-12-3149.95M+22.2%2025-03-06, Balance as of period end
2022-12-3140.86M+0.7%2024-03-07, Balance as of period end
2021-12-3140.59M+1.9%2023-03-09, Balance as of period end
2020-12-3139.84Mn/m2022-02-28, Balance as of period end
2019-12-313.17Mn/a2021-03-18, Balance as of period end